Roger Md Medel - Dec 27, 2021 Form 4 Insider Report for MEDNAX, INC. (MD)

Role
Director
Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Dec 27, 2021
Transactions value $
-$3,713,145
Form type
4
Date filed
12/29/2021, 04:31 PM
Previous filing
Oct 29, 2021
Next filing
Dec 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Sale -$1.82M -66.9K -5.93% $27.17 1.06M Dec 27, 2021 Direct F1, F2
transaction MD Common Stock Sale -$1.21M -44.5K -4.2% $27.28 1.02M Dec 28, 2021 Direct F1, F3
transaction MD Common Stock Sale -$682K -25K -2.46% $27.28 991K Dec 29, 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.84 to $27.48 for a weighted average sales price of $27.17. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $27.15 to $27.71 for a weighted average sales price of $27.28. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.98 to $27.43 for a weighted average sales price of $27.28. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.